These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 72989)

  • 21. Letter: Susceptibility of Bacteroides fragilis to co-trimoxazole.
    Okubadejo OA
    Lancet; 1974 May; 1(7865):1061. PubMed ID: 4133750
    [No Abstract]   [Full Text] [Related]  

  • 22. Resistance to co-trimoxazole.
    McAllister TA
    Scand J Infect Dis Suppl; 1976; (8):29-38. PubMed ID: 1084551
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 24. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 25. [Resistance patterns of certain Enterobacteriaceae in hospital and outpatients, with particular reference to trimethoprim-sulfamethoxazole (author's transl)].
    Freitag V
    MMW Munch Med Wochenschr; 1976 Feb; 118(9):275-8. PubMed ID: 817195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of bacterial resistance to trimethoprim-sulphamethoxazole using the single disc diffusion method.
    Kayser FH; Wüst J
    Chemotherapy; 1973; 18(3):162-8. PubMed ID: 4567769
    [No Abstract]   [Full Text] [Related]  

  • 27. Emergence of sulfamethoxazole-trimethoprim resistant Shigella flexneri in Northeastern Brazil.
    Tiemens KM; Shipley PL; Correia RA; Shields DS; Guerrant RL
    Arq Gastroenterol; 1985; 22(4):162-5. PubMed ID: 3915680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance of enterobacteria to the sulfonamide-trimethoprim combination. Course during the last 10 years].
    Goldstein FW; Acar JF
    Presse Med; 1983 May; 12(21):1341-4. PubMed ID: 6222315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemic Shigella sonnei resistant to co-trimoxazole.
    Pérez Trallero E; López Lopatequi C; Jiménez Alfaro JA; García Arenzana JM
    Lancet; 1981 Oct; 2(8249):751. PubMed ID: 6116883
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia.
    Wilson JM; Guiney DG
    N Engl J Med; 1982 Jan; 306(1):16-20. PubMed ID: 7053467
    [No Abstract]   [Full Text] [Related]  

  • 31. High prevalence of non-epidemic Shigella sonnei resistant to co-trimoxazole.
    Palenque E; Otero JR; Noriega AR
    J Antimicrob Chemother; 1983 Feb; 11(2):196-8. PubMed ID: 6339462
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-trimoxazole resistant mycobacterium marinum.
    Cunningham MJ; White PM; Samman PD
    Br J Dermatol; 1978 Nov; 99(5):597. PubMed ID: 708634
    [No Abstract]   [Full Text] [Related]  

  • 36. [In vitro sensitivity (MIC) of Gram-negative bacilli exposed to the combination of trimethoprim-sulfamethopyrazine (Kelfiprim)].
    Prado V; Aguirre X; Pinto ME; Soledad Giglio M
    Rev Med Chil; 1982 Jan; 110(1):29-32. PubMed ID: 6818651
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Effect of urine from individuals receiving either co-trimoxazole or its separate components upon urinary gram-negative bacteria.
    Anderson JD; Sellin MA; Lacey RW
    J Clin Pathol; 1974 Jun; 27(6):512-3. PubMed ID: 4415253
    [No Abstract]   [Full Text] [Related]  

  • 38. Combinations of antimicrobial agents. III. The in vitro sensitivity of 12 strains of Pseudomonas aeruginosa and 12 strains of proteus species ot sulphamethoxazole + trimethoprim (co-trimoxazole), polymyxins and combinations of co-trimoxazole and polymyxins.
    Kuipers JS
    Arch Chir Neerl; 1976; 28(2):91-9. PubMed ID: 823875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cefaclor, phenethicillin, co-trimoxazole and doxycycline on colonization resistance in healthy volunteers.
    Vollaard EJ; Clasener HA; van Griethuysen AJ; Janssen AJ; Sanders-Reijmers AH; Muller NF; Huige PJ
    J Antimicrob Chemother; 1988 Nov; 22(5):747-58. PubMed ID: 3145269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.
    Anderson JD; Lacey RW; Lewis EL; Sellin MA
    J Clin Pathol; 1974 Aug; 27(8):619-22. PubMed ID: 4425219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.